Login

Sandro Tobler, VP of Fiber Optic Technology and Operations, shares his experience working at HUBER+SUHNER. 00:10:00

Share On Facebook Share On Twitter

Urs Ryffel is Chief Executive Officer, Huber + Suhner AG.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Marathoon Fund Management , Managing Director at Firefinch Limited
00:10:00
Creating Vibrant Urban Destinations: CEO Discusses Future Workplaces and Brewery Project Transformation | Nicklas Lindberg, CEO, Echo Investment SA.
00:10:00
Collaborating for Responsible Ownership: Uniting the Private Equity Industry for Positive Chang
00:10:00
HighGold CEO Discusses Exciting Copper-Gold Projects at 1-2-1 Mining Conference in New York
00:10:00
Eurazeo's Strategic Shift: Adapting Amid Sector Dislocations and Embracing Sustainability Goals | Virginie Morgon, CEO, Eurazeo.
00:00:00
Karen Aiach, CEO, Lysogene
00:10:00
Introducing GOVERN Function and Enhanced Framework Functions | Domenico Favuzzi, President & CEO of Exprivia SpA
00:10:00
Journey to Retirement: Achieving and Embracing the Golden Years | Matthew Kelley - President of Gold Medal Waters, Inc.
00:10:00
AZEK CEO Jesse Singh Discusses Company's Public Debut on CNBC | Jesse Singh - Chief Executive Officer, President and Director of azek company inc
00:10:00
Unlocking Success with Our Technical Advisory Services Team | Rajiv Sharma, Group CEO, Coats Group PLCCOA:LSE
00:10:00
Matt Brown and Lee Beck in Conversation on Finance, Technology, and Alternative Investments
00:10:00
The Marathon of Investing: Parallels Between Running and Financial Planning | B.Gopkumar, CEO , Axis Mutual Fund.

© 2017 - Neuhu+